M. Rinaldi

发表

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

J. Spertus, J. Massaro, L. Mauri, 2016, JAMA.

Impact of Point-of-Care Platelet Function Testing Among Patients With and Without Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study).

G. Stone, A. Kirtane, F. Neumann, 2019, The American journal of cardiology.

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.

Peter L Duffy, G. Stone, T. Henry, 2017, JACC. Cardiovascular interventions.

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.

A. Jacobs, S. Windecker, J. Massaro, 2015, Journal of the American College of Cardiology.

Transcatheter Mitral‐Valve Repair in Patients with Heart Failure

M. Mack, G. Stone, N. Weissman, 2018, The New England journal of medicine.

Effect of Obesity on Coronary Atherosclerosis and Outcomes of Percutaneous Coronary Intervention: Grayscale and Virtual Histology Intravascular Ultrasound Substudy of Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents

Peter L Duffy, G. Stone, A. Kirtane, 2014, Circulation. Cardiovascular interventions.

Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study

Peter L Duffy, G. Stone, T. Henry, 2013 .

Impact of high on‐aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug‐eluting stents

Peter L Duffy, G. Stone, T. Henry, 2018, American heart journal.

Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy.

Peter L Duffy, G. Stone, A. Kirtane, 2017, International journal of cardiology.

Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES

G. Stone, A. Kirtane, F. Neumann, 2015, Circulation. Cardiovascular interventions.

Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study

Peter L Duffy, G. Stone, T. Henry, 2015, Circulation. Cardiovascular interventions.

Treatment of intracoronary thrombus with local urokinase infusion using a new, site-specific drug delivery system: the Dispatch catheter.

D. Waters, M. Rinaldi, J. Hirst, 1994, Catheterization and cardiovascular diagnosis.

Prevalence, Features, and Prognostic Importance of Edge Dissection After Drug-Eluting Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy

Peter L Duffy, G. Stone, A. Kirtane, 2016, Circulation. Cardiovascular interventions.

3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.

M. Mack, G. Stone, N. Weissman, 2021, Journal of the American College of Cardiology.

Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).

Peter L Duffy, G. Stone, A. Kirtane, 2015, The American journal of cardiology.

Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug‐Eluting Stents (ADAPT‐DES) study

Peter L Duffy, G. Stone, T. Henry, 2019, American heart journal.

Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention.

G. Stone, G. Weisz, R. Mehran, 2022, JACC. Cardiovascular interventions.

Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents.

Peter L Duffy, G. Stone, T. Henry, 2017, International journal of cardiology.

The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study.

Peter L Duffy, G. Stone, T. Henry, 2016, JACC. Cardiovascular interventions.

Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES.

Peter L Duffy, G. Stone, T. Henry, 2021, JACC. Cardiovascular interventions.

Differences in Underlying Culprit Lesion Morphology Between Men and Women: An IVUS Analysis From the ADAPT-DES Study.

Peter L Duffy, G. Stone, A. Kirtane, 2016, JACC Cardiovascular Imaging.

Relation Between Renal Function and Coronary Plaque Morphology ( From the ADAPT-DES Virtual Histology-Intravascular Ultrasound Substudy ) Brief title : Coronary Plaque Morphology in CKD

Peter L Duffy, G. Stone, A. Kirtane, 2016 .

Relation Between Renal Function and Coronary Plaque Morphology (from the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Virtual Histology-Intravascular Ultrasound Substudy).

Peter L Duffy, G. Stone, A. Kirtane, 2017, The American journal of cardiology.

Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Registry

Peter L Duffy, G. Stone, T. Henry, 2015, Circulation. Cardiovascular interventions.

2-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study.

J. Carroll, W. O’Neill, S. Windecker, 2021, JACC. Cardiovascular interventions.

Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.

T. Ryan, H. Dauerman, A. Kirtane, 2008, American heart journal.

Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention: Findings From the ADAPT-DES Study.

G. Stone, A. Kirtane, G. Weisz, 2019, Circulation. Cardiovascular Interventions.

Peter L Duffy, G. Stone, A. Kirtane, 2015, Coronary artery disease.

Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).

Peter L Duffy, G. Stone, T. Henry, 2015, JACC. Cardiovascular interventions.

Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents)

Peter L Duffy, G. Stone, S. Ooi, 2017, Circulation. Cardiovascular interventions.

Impact of high on‐treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT‐DES substudy

Peter L Duffy, G. Stone, T. Henry, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

1-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study.

W. O’Neill, R. Boone, J. Webb, 2020, JACC. Cardiovascular interventions.

Relationship Between Platelet Reactivity and Culprit Lesion Morphology: An Assessment From the ADAPT-DES Intravascular Ultrasound Substudy.

Peter L Duffy, G. Stone, A. Kirtane, 2016, JACC. Cardiovascular imaging.

Relationship Between Platelet Reactivity and Culprit Lesion Morphology

Peter L Duffy, G. Stone, G. Weisz, 2022 .

Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study.

Peter L Duffy, G. Stone, T. Henry, 2016, The American journal of cardiology.

Transcatheter Valve Repair for Patients With Mitral Regurgitation: 30-Day Results of the CLASP Study.

W. O’Neill, J. Webb, T. Feldman, 2019, JACC. Cardiovascular interventions.

Left Ventricular Size and Secondary MR: A Harbinger of PMVR Success?

M. Rinaldi, J. Schwartz, N. Kelly, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study).

Peter L Duffy, G. Stone, T. Henry, 2019, The American journal of cardiology.

DOES PLATELET FUNCTION TESTING ADD SIGNIFICANT INCREMENTAL RISK STRATIFICATION TO UNSELECTED PATIENTS UNDERGOING DES IMPLANTATION? THE ADAPT-DES STUDY

G. Stone, T. Henry, A. Kirtane, 2012 .

Postpartum dissection of the left main coronary artery

W. Boden, J. Dougherty, M. Rinaldi, 2006, Clinical cardiology.

Antiplatelets and AntithrombinsTCT-152 Is There a Therapeutic Window For Platelet Responsiveness Among PCI Patients? Analysis from the ADAPT-DES Study

Peter L Duffy, G. Stone, T. Henry, 2013 .

Prevalence and Clinical Impact of Tissue Protrusion After Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy.

Peter L Duffy, G. Stone, A. Kirtane, 2016, JACC. Cardiovascular interventions.

Impact of chronic statin therapy on clinical presentation and underlying lesion morphology in patients undergoing percutaneous intervention: an ADAPT-DES IVUS substudy

Peter L Duffy, G. Stone, A. Kirtane, 2017, Coronary Artery Disease.

Outcomes of Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation by Severity of Left Ventricular Dysfunction.

Samin K. Sharma, M. Mack, G. Stone, 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES.

Peter L Duffy, G. Stone, Z. Ali, 2021, JACC. Cardiovascular interventions.

IMPACT OF POINT–OF–CARE PLATELET FUNCTION TESTING AMONG PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROMES UNDERGOING PCI WITH DRUG–ELUTING STENTS: AN ADAPT–DES SUBSTUDY

Peter L Duffy, G. Stone, T. Henry, 2012 .

Current clinical characteristics and economic impact of subacute stent thrombosis.

D. Cohen, D. Pinto, M. Rinaldi, 2002, The Journal of invasive cardiology.

Percutaneous repair or surgery for mitral regurgitation.

Saibal Kar, Catalin Loghin, Laura Mauri, 2011, The New England journal of medicine.

Characterization of Cerebral Embolic Capture Using the SENTINEL Device During Transcatheter Aortic Valve Implantation in Low to Intermediate-Risk Patients: The SENTINEL-LIR Study

R. Virmani, A. Finn, T. Nazif, 2022, Circulation. Cardiovascular interventions.

Predictors and Long‐Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug‐Eluting Stents (ADAPT‐DES) Intravascular Ultrasound Substudy

Peter L Duffy, Bin Wang, G. Stone, 2016, Journal of the American Heart Association.

Should interventional cardiologists treat ischemic strokes? A global perspective.

E. Levy, M. Harrigan, B. Bendok, 2002, The Journal of invasive cardiology.

Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: Two-Year Follow-Up of the ADAPT-DES Study

Peter L Duffy, G. Stone, T. Henry, 2018, Circulation. Cardiovascular interventions.

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Braunwald, S. Normand, E. Braunwald, 2014, The New England journal of medicine.

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study

Peter L Duffy, G. Stone, T. Henry, 2013, The Lancet.

Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents)

G. Stone, A. Kirtane, G. Weisz, 2017, Circulation. Cardiovascular interventions.

Carotid stenting: Innovation results in a standardized procedure

M. Rinaldi, K. Rosenfield, 2002 .

Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation.

G. Stone, V. Rajagopal, B. Whisenant, 2023, The New England journal of medicine.

Incidence and Standardized Definitions of Mitral Valve Leaflet Adverse Events After Transcatheter Mitral Valve Repair: the EXPAND Study.

F. Asch, F. Maisano, M. Rinaldi, 2021, EuroIntervention.

Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention.

Peter L Duffy, G. Stone, T. Henry, 2015, Journal of the American College of Cardiology.

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II.

M. Mack, M. Acker, E. Foster, 2015, Journal of the American College of Cardiology.

Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study.

Peter L Duffy, G. Stone, T. Henry, 2018, JACC. Cardiovascular interventions.

Practice gaps in the care of mitral valve regurgitation: Insights from the American College of Cardiology mitral regurgitation gap analysis and advisory panel.

Randolph P. Martin, M. McCulloch, V. Thourani, 2016, American heart journal.

Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.

M. Mack, G. Stone, B. Whisenant, 2019, Circulation.

Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients With Primary Mitral Regurgitation Who Are Candidates for Surgery: Design and Rationale of the REPAIR MR Trial.

Randolph P. Martin, P. McCarthy, B. Whisenant, 2023, Journal of the American Heart Association.

Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke.

M. Mack, M. Leon, S. Kapadia, 2019, JAMA.

Percutaneous Mitral Valve Repair in the Initial EVEREST Cohort: Evidence of Reverse Left Ventricular Remodeling

N. Weissman, E. Foster, D. Glower, 2013, Circulation. Cardiovascular imaging.

On‐Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two‐Year Results From ADAPT‐DES

Peter L Duffy, G. Stone, F. Neumann, 2022, Journal of the American Heart Association.

Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study.

Peter L Duffy, G. Stone, T. Henry, 2017, International journal of cardiology.

Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial

H. Lutsep, K. Beach, T. Brott, 2012, The Lancet Neurology.

Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study.

M. Mack, T. Bajwa, P. McCarthy, 2014, Journal of the American College of Cardiology.

Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke Among Patients at Low Surgical Risk.

M. Mack, M. Leon, S. Kapadia, 2021, JAMA.

Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Study

Gary S. Mintz, Akiko Maehara, Timothy D. Henry, 2014, Circulation.

Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study).

Peter L Duffy, G. Stone, T. Henry, 2017, The American journal of cardiology.

Sex-Specific Outcomes of Transcatheter Mitral-Valve Repair and Medical Therapy for Mitral Regurgitation in Heart Failure.

M. Mack, G. Stone, V. Rajagopal, 2021, JACC. Heart failure.

Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation: The COAPT Trial.

M. Mack, G. Stone, V. Rajagopal, 2020, Journal of the American College of Cardiology.

TCT-486 Additive And Independent Impact Of Chronic Kidney Disease And Diabetes Mellitus On High Platelet Reactivity And Adverse Events Following PCI: Results From The ADAPT-DES Registry

G. Stone, T. Henry, A. Kirtane, 2014 .

Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study.

Peter L Duffy, G. Stone, T. Henry, 2016, The American journal of cardiology.

Vena cava filter options: what’s on the horizon?

M. Rinaldi, R. Sing, M. Lessne, 2016, Expert review of cardiovascular therapy.

Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population: Analysis From the ADAPT-DES Registry

Peter L Duffy, G. Stone, T. Henry, 2018, Circulation. Cardiovascular interventions.

Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES Study

Peter L Duffy, G. Stone, T. Henry, 2015, Circulation. Cardiovascular interventions.

Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study).

Peter L Duffy, G. Stone, T. Henry, 2016, The American journal of cardiology.

Achieving sustainable first door-to-balloon times of 90 minutes for regional transfer ST-segment elevation myocardial infarction.

M. Rinaldi, William E. Downey, G. Kowalchuk, 2013, JACC. Cardiovascular interventions.

Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy.

A. Jeremias, G. Stone, Z. Ali, 2022, JACC. Cardiovascular interventions.

Natural history of mitral valve prolapse.

R. Devereux, M. Roman, M. Rinaldi, 1995, The American journal of cardiology.

Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES

F. Neumann, G. Weisz, R. Mehran, 2015, Circulation. Cardiovascular Interventions.

Transcatheter Mitral‐Valve Repair in Patients with Heart Failure

M. Mack, G. Stone, N. Weissman, 2018, The New England journal of medicine.

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.

S. Windecker, J. Massaro, L. Mauri, 2015, Journal of the American College of Cardiology.

Real-World Outcomes of Fourth-Generation Mitral Transcatheter Repair: 30-Day Results From EXPAND G4.

M. Price, F. Asch, P. Denti, 2023, JACC. Cardiovascular interventions.

Expanding the Spectrum of TEER Suitability: Evidence From the EXPAND G4 Post Approval Study.

M. Price, F. Asch, P. Denti, 2023, JACC. Cardiovascular interventions.

Three‐year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study

J. Carroll, S. Windecker, J. Webb, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study

Peter L Duffy, F. Neumann, G. Weisz, 2015, Circulation. Cardiovascular interventions.

Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial.

Andrew S. Mugglin, Samin K. Sharma, P. Teirstein, 2020, JACC. Cardiovascular interventions.